文献速递头颈外科咽喉与嗓音

经口机器人手术治疗口咽涎腺恶性肿瘤的全国性分析

National Analysis of Oropharyngeal Salivary Gland Malignancies Treated With Transoral Robotic Surgery.
PubMed 文献 · Otolaryngol Head Neck Surg · 2021-07-27

基于美国国家癌症数据库2010-2017年785例T1-T4a无远处转移的口咽涎腺恶性肿瘤手术患者,比较经口机器人手术(TORS)与非机器人手术的围手术期结局和总生存。

要点

  • 两组切缘阳性率、30天死亡率和总生存无显著差异。

核心结论

  • TORS可能是经过适当选择的口咽涎腺恶性肿瘤患者的可行治疗方式。

研究设计与样本

  • 回顾性分析美国国家癌症数据库(NCDB)2010-2017年数据,纳入785例T1-T4a无远处转移的口咽涎腺恶性肿瘤手术患者,按手术方式分为TORS组与非机器人组。

主要发现

  • 两组切缘阳性率、30天死亡率和总生存无显著差异。
  • 非软腭原发部位(OR=12.9,95%CI 6.6-25.2)和学术机构治疗(OR=2.0,95%CI 1.2-3.5)与采用TORS独立相关。

临床怎么用

  • 对于经适当选择的口咽涎腺恶性肿瘤患者,TORS可作为可行的手术选择。
  • 采用TORS时需关注30天非计划再入院风险。
  • 舌根肿瘤患者采用TORS可能缩短住院时间。

局限性

  • 本研究为基于NCDB的回顾性分析,存在数据库固有局限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: (1) To compare perioperative outcomes and overall survival of patients with oropharyngeal salivary gland malignancies (OPSGMs) treated with transoral robotic surgery (TORS) versus other approaches. (2) To identify clinical factors associated with a robotic surgical approach. STUDY DESIGN: Retrospective analysis of the National Cancer Database (NCDB). SETTING: NCDB. METHODS: Data obtained from the NCDB were analyzed between 2010 and 2017 for patients with T1-T4a OPSGMs without distant metastases treated surgically. Patients were stratified by surgical approach (TORS vs nonrobotic), and clinicopathologic factors were compared with the t test or chi-square test for continuous or categorical variables, respectively. Overall survival was analyzed by patient demographics and clinical factors according to Kaplan-Meier and Cox proportional hazards models. Factors associated with TORS were assessed with logistic regression. RESULTS: A total of 785 patients were analyzed. A non-soft palate primary site (odds ratio, 12.9; 95% CI, 6.6-25.2) and treatment at an academic facility (odds ratio, 2.0; 95% CI, 1.2-3.5) were independently associated with TORS. There were no significant differences in the positive margin rate, 30-day mortality, or overall survival between the groups. The 30-day unplanned readmission rate was higher in patients treated with TORS versus nonrobotic resections (5.8% vs 1.7%, P = .0004). When stratified by tumor subsite, there was a significant decrease in hospital length of stay in patients with tongue base tumors undergoing TORS versus nonrobotic resections (P = .029). CONCLUSION: This study suggests that TORS may be a viable treatment modality for appropriately selected patients with OPSGM.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Bollig CA, Wang K, Llerena P, et al. National Analysis of Oropharyngeal Salivary Gland Malignancies Treated With Transoral Robotic Surgery. Otolaryngol Head Neck Surg. 2021. PMID: 34311621. doi:10.1177/01945998211031161

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。